Publicly Listed MEI Pharma Completes $100 Million Private Placement to Build Litecoin Strategic Reserves
Odaily Planet Daily News: MEI Pharma announced the completion of a $100 million private placement, selling 29,239,767 shares of common stock or equivalent prepaid warrants at a price of $3.42 per share. The proceeds will be used to establish a Litecoin strategic reserve.
The company has also appointed Charlie Lee, founder of Litecoin and lead investor in this private placement, to its board of directors, and designated GSR as its digital asset and fund management advisor, responsible for overseeing the execution of the Litecoin reserve strategy. (businesswire)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Jefferies lowers SEA target price to $142
Zenix Robotics Invests 5.08 Billion Won to Expand Production Capacity
Anthropic (ANT.US) targets IPO at trillion-dollar valuation; venture capitalists warn it may signal the peak of the AI market
Venture capitalist Selby warns that Anthropic’s trillion-dollar valuation IPO could signal the peak of the AI market, and the expiration of the lock-up period may trigger a chain reaction of corrections.
Wall Street's "Great Rotation" Underway: AI Trading Fades, Tech Stocks Out of Favor, Capital Flows Shift to Defensive Sectors
Analysts point out that as investors shift their bets from high-risk technology sectors to defensive stocks, the market is currently in a "state of alert".
Crypto prices
More
